-
On "Florida Matters Live & Local" with guest host Cathy Carter, changes to the Endangered Species Act, the enduring wit of Mark Twain, massive soaring artwork and a dragon boat team of breast cancer survivors.
-
Sasse, 53, made the announcement on social media, saying he learned of the disease last week and is “now marching to the beat of a faster drummer.”
-
A South Florida man claims long-term use of the herbicide led to his diagnosis with non-Hodgkin’s lymphoma. He is suing the product's Germany-based manufactuer, Bayer.
-
The largest slice is a $277.5 million package for cancer research, along with investments in emergency medical innovation and public health infrastructure.
-
Matthew Milton Bravo, who was diagnosed with Stage 2 Hodgkin's lymphoma, says he will be finishing chemotherapy by the end of December.
-
Dr. Christopher Ellington, a thoracic surgeon at Ascension Sacred Heart, is the only doctor in the Pensacola area performing the single anesthesia dual robotic lung biopsy and resection.
-
A former NIH director discusses the urgent need to put public health above party lines. Then, a cancer survivor reflects on his diagnosis and the complex procedure that saved his life.
-
After learning his diagnosis, Matthew Bravo's first instinct was to help others. And it inspired his frat brothers, too. "I don't wanna say I didn't flinch at the diagnosis, but I was just ready to get started," he said.
-
Johns Hopkins All Children’s, Nemours Children’s, Nicklaus Children’s and Wolfson Children’s are each receiving $7.5 million annually over five years as part of a collaborative program funded by the state.
-
Patients will have the ability to take a five-minute survey to see if they should receive genetic testing.
-
A study out of UF and MD Anderson Cancer Center shows patients with advanced lung or skin cancer taking certain drugs lived longer if they also got a COVID shot within 100 days of starting treatment.
-
Former President Joe Biden's treatment for an aggressive form of prostate cancer has entered a new phase.